| 000 | 01464 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518080430.0 | ||
| 264 | 0 | _c20200129 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1536-5964 | ||
| 024 | 7 |
_a10.1097/MD.0000000000018680 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Hung-Ming | |
| 245 | 0 | 0 |
_aSimilar thrombolysis outcomes in acute stroke patients with and without atrial fibrillation if pre-stroke CHA2DS2-VASc score is low: A retrospective study. _h[electronic resource] |
| 260 |
_bMedicine _cJan 2020 |
||
| 300 |
_ae18680 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aStroke _xcomplications |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 700 | 1 | _aChung, Chih-Ping | |
| 700 | 1 | _aLin, Yung-Yang | |
| 773 | 0 |
_tMedicine _gvol. 99 _gno. 2 _gp. e18680 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MD.0000000000018680 _zAvailable from publisher's website |
| 999 |
_c30495780 _d30495780 |
||